Verona Pharma | 10-Q: Quarterly report
Verona Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Verona Pharma | 8-K: Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
Verona Pharma | 8-K: Current report
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Hahn Mark W
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Rickard Kathleen A.
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer ZACCARDELLI DAVID
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director Deschamps Lisa
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director Brady James Aloysius
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director Sinha Vikas
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director Cunningham Kenneth
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director SHAH MAHENDRA
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director ACKERMANN CHRISTINA
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director EBSWORTH DAVID R
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director Ullman Anders
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Director Edwards Martin
Verona Pharma | 8-K: Current report
Verona Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Fisher Andrew
Verona Pharma | ARS: Annual Report to Security Holders
Verona Pharma | DEF 14A: Definitive information statements
No Data